• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.
 

IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.

Options
  • Details
BORIS DOI
10.7892/boris.131556
Date of Publication
September 1, 2019
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Contributor
Wójtowicz, Agnieszka
Bibert, Stéphanie
Taffé, Patrick
Bernasconi, Enos
Furrer, Hansjakoborcid-logo
Universitätsklinik für Infektiologie
Günthard, Huldrych F
Hoffmann, Matthias
Osthoff, Michael
Cavassini, Matthias
Bochud, Pierre-Yves
Subject(s)

600 - Technology::610...

Series
AIDS
ISSN or ISBN (if monograph)
0269-9370
Publisher
Lippincott Williams & Wilkins
Language
English
Publisher DOI
10.1097/QAD.0000000000002283
PubMed ID
31225812
Description
OBJECTIVES

Pneumocystis jirovecii pneumonia (PJP) is an important cause of morbidity and mortality in HIV-positive patients. Polymorphisms in immune genes are increasingly reported to influence susceptibility to fungal infections. We analysed the role of 21 single nucleotide polymorphisms from 19 candidate genes on PJP development in patients from the Swiss HIV Cohort Study.

DESIGN AND METHODS

The analysis included patients with a nadir CD4 T-cell count less than 200 cells/μl, divided into a discovery (N = 1645) and a replication (N = 1861) cohort. The associations were analysed by using cumulative incidence curves as well as competing risk regression over 18 years, starting from the estimated date of HIV infection, considering death a competing risk, with censoring at lost follow-up, and assuming the dominant mode of inheritance.

RESULTS

The minor allele of rs2243250 in IL-4 was associated with the risk of PJP in the discovery cohort (cumulative incidence 0.18 versus 0.12, P = 0.002). This association was replicated in the validation cohort (0.16 versus 0.12, P = 0.02). It was still significant in multivariate models, adjusted for HIV transmission mode, viral load, CD4 T cells slope, age, antiretroviral therapy, tobacco smoking, hepatitis C virus coinfection, year of cohort entry and PJP prophylaxis (global subhazard ratio 1.42, 95% confidence interval 1.17-1.73, P = 0.0004).

CONCLUSION

Our data suggest rs2243250, a single nucleotide polymorphism known to influence IL-4 production, is associated with susceptibility to PJP in HIV-positive patients.This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/180948
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
IL_4_polymorphism_influences_susceptibility_to.6.pdftextAdobe PDF271.16 KBpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 960e9e [21.08. 13:49]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo